Clinical trial · Observational
Chemotherapy and Tumor Clearance in Hepatic Resections for Colorectal Liver Metastases.
Effect of Chemotherapy and Tumor Clearance in Hepatic Resections for Colorectal Liver Metastases. A Single-centre Cohort Study
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Retrospective analysis of a prospectively collected database of 170 patients between 2004 and 2020, who underwent liver resections for CRLM (colorectal liver metastases) at The Queen Elizabeth Hospital trying to determine rates and patterns of recurrence following liver resections for CRLM and concurrently, characterise clinical, pathological and treatment-related factors that could function as predictors of recurrence or survival, particularly neoadjuvant chemotherapy and tumour clearance.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Colorectal Cancer Metastatic | — | UNRESOLVED | — |
| Liver Metastases | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Hepatectomy | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (2)
- measure
- Recurrence
- timeFrame
- From surgery to recurrence, up to 16 years
- description
- Recurrence rate
- measure
- Survival
- timeFrame
- From surgery to death or end of the study, up to 16 years
- description
- up to16 years
Secondary outcomes (2)
- measure
- Resection margins
- timeFrame
- From surgery to death or end of the study, up to 16 years
- description
- Resection margins of the liver resection
- measure
- Neoadjuvant Chemotherapy
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patients who underwent a liver resection for CRLM at The Queen Elizabeth Hospital between December 2004 to September 2020 Exclusion Criteria: * Patients whose procedures were abandoned due to unresectable tumour burden
References
Publications (0)
Data not yet available